Mizrahi; Jacques
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mizrahi; Jacques.The latest application filed is for "telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction".
- Mizrahi; Jacques - Bottmingen CH
- Mizrahi; Jacques - Basel CH
- Mizrahi, Jacques - Basle CH
- Mizrahi; Jacques - Cinisello Balsamo IT
- Mizrahi; Jacques - Milan IT
| Patent | Date |
|---|---|
| Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction Grant 11,261,434 - Blasco Marhuenda , et al. March 1, 2 | 2022-03-01 |
| Telomerase Reverse Transcriptase-based Therapies For Treatment Of Conditions Associated With Myocardial Infarction App 20170191045 - BLASCO MARHUENDA; Maria Antonia ; et al. | 2017-07-06 |
| Piperazine derivatives Grant 7,022,707 - Adams , et al. April 4, 2 | 2006-04-04 |
| Screening assays App 20050158771 - Clerc, Roger G. ; et al. | 2005-07-21 |
| Screening assays App 20050136465 - Clerc, Roger G. ; et al. | 2005-06-23 |
| Novel piperazine derivatives App 20040235859 - Adams, David Reginald ; et al. | 2004-11-25 |
| Fused indole derivatives Grant 6,610,685 - Bentley , et al. August 26, 2 | 2003-08-26 |
| Treatment of metabolic diseases with soraphen derivatives App 20030144345 - Gubler, Marcel ; et al. | 2003-07-31 |
| Novel indole derivatives App 20020160997 - Bentley, Jonathan Mark ; et al. | 2002-10-31 |
| Novel piperazine derivatives App 20020143020 - Adams, David Reginald ; et al. | 2002-10-03 |
| Analogues of the active metabolite of leflunomide Grant 5,905,090 - Bertolini , et al. May 18, 1 | 1999-05-18 |
| Imidazole ethers having a II antagonist activity Grant 5,538,987 - Salimbeni , et al. July 23, 1 | 1996-07-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 